CIRCHE — CirChem AB Income Statement
0.000.00%
Last trade - 00:00- SEK47.91m
- SEK44.91m
- SEK20.66m
Annual income statement for CirChem AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.073 | 0.086 | 0.591 | 5.74 | 20.7 |
| Cost of Revenue | |||||
| Gross Profit | -6.79 | -12.2 | -12.2 | -5.24 | 12.1 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 9.01 | 16.9 | 20.5 | 21.4 | 20.6 |
| Operating Profit | -8.93 | -16.8 | -20 | -15.6 | 0.104 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -9.49 | -18.2 | -22.7 | -17.1 | -1.07 |
| Net Income After Taxes | -9.49 | -18.2 | -22.7 | -17.1 | -1.07 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -9.49 | -18.2 | -22.7 | -17.1 | -1.07 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -9.49 | -18.2 | -22.7 | -17.1 | -1.07 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.634 | -1.21 | -1.19 | -0.594 | -0.035 |
| Dividends per Share |